Teracero Pharma anno
Teracero Pharma annonce avoir reçu la première autorisation au Canada en vertu de l'arrêté d’urgence du ministre de la Santé pour un test sérologique rapide pour la COVID-19
March 17, 2021 14:00 ET | Teracero Pharma Inc.
Le test NADAL COVID-19 IgG/IgM de nal von Minden GmbH est très sensible et spécifique aux anticorps contre le SRAS-CoV-2, ne nécessite aucune formation particulière et fournit des résultats en 10...
teräcero round logo rbg 600.png
A new stage in COVID-19 testing – Teracero Pharma reports receiving the first authorization for a COVID-19 serology rapid test under the Minister of Health’s Interim Order
March 17, 2021 14:00 ET | Teracero Pharma Inc.
nal von Minden GmbH’s NADAL COVID-19 IgG/IgM Test is highly sensitive and specific to antibodies against SARS-CoV-2, requires no special training, and can provide results within 10 minutes MONTREAL,...
Luminostics Announces FDA Authorization and Production Scale-Up of US-Manufactured Smartphone-Based COVID-19 Rapid Test
February 16, 2021 05:30 ET | Luminostics
Luminostics’s Clip COVID Rapid Antigen Test uses a smartphone-based analyzer to obtain results in 30 minutes from nasal swabs in decentralized settingsClip COVID’s emergency use authorization (EUA) in...
PRPO logo.png
Precipio Launches COVID-19 Antibody Testing at Point-of-Care
January 28, 2021 09:30 ET | Precipio, Inc.
NEW HAVEN, Conn., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that following receipt of an Emergency Use Authorization from the FDA...
22157.jpg
Global Antigen Rapid Test Kit Market, Forecast & Opportunities, 2026 - Over-the-counter (OTC) Rapid Test Kit v/s Professional Rapid Test Kit
January 28, 2021 05:28 ET | Research and Markets
Dublin, Jan. 28, 2021 (GLOBE NEWSWIRE) -- The "Global Rapid Test Kit Market by Type (Rapid Antigen Test v/s Rapid Antibody Test), by Product Type (Over-the-counter (OTC) Rapid Test Kit v/s...
22157.jpg
Global Immunoassay Markets, Strategies and Trends Report 2021: Multiplex and Point of Care Market Analysis & Forecasts 2019-2023
January 25, 2021 04:58 ET | Research and Markets
Dublin, Jan. 25, 2021 (GLOBE NEWSWIRE) -- The "Immunoassay Markets Strategies and Trends. Forecasts by Instrument Type and by Application and by Country. With Multiplex and Point of Care Market...
5ef2af588104f70ce6d76d97_1.jpg
Global WholeHealth Partners Corp (GWHP-OTC) to Announce that Global is Now Selling Access Bio Antigen Test
January 21, 2021 06:30 ET | Global WholeHealth Partners Corp.
Antigen Testing is Essential to Keep the Fight Against CoViD19 SARS 2 SAN CLEMENTE, CA, Jan. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Charles Strongo, CEO of Global WholeHealth Partners...
5ef2af588104f70ce6d76d97_1.jpg
Global WholeHealth Partners Corp (GWHP-OTC) to Announce that the Antibody Test Kits Offered by Global Can Detect the Mutated COVID-19 Strain
January 20, 2021 06:30 ET | Global WholeHealth Partners Corp.
Global's Antibody Test Can Detect the New CoViD 19 SARS 2 Strain SAN CLEMENTE, CA, Jan. 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Charles Strongo, CEO of Global WholeHealth Partners Corp...
The PixoTest POCT Analyzer scans the QR Code ID from PixoHealth Pass User
iXensor to close the loop of COVID-19 outbreak prevention with the fully digitalized rapid antigen test and an encrypted mobile pass
December 17, 2020 02:35 ET | iXensor Co., LTD.
TAIPEI, TAIWAN and PALO ALTO, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) -- iXensor Co., Ltd. (6734.TWO) iXensor, the pioneer of mobile health, infuses its corporate DNA of digital savviness into its...
22157.jpg
Immunoassays - Worldwide Industry Analysis (2019-2023) with Profiles of 44 Companies
August 26, 2020 10:23 ET | Research and Markets
Dublin, Aug. 26, 2020 (GLOBE NEWSWIRE) -- The "Immunoassay Markets Strategies and Trends. Forecasts by Instrument Type and by Application and by Country. With Multiplex and Point of Care Market...